Last updated 7 days ago

SBRT-LATTICE-PATHY

20 patients around the world

Available in Brazil

University of Sao Paulo General Hospital

1Research sites

20Patients around the world

This study is for people with

Solid tumors

From 18 Years

All Gender

: Age =or> 18 years.
Eastern Cooperative Oncology Group (ECOG) performance status < 2; benign and malignant tumors for which the use of radiotherapy is well established in the literature.
Tumors =or> 340 cm³ or with a largest diameter =or> 7 cm.
No indication for any other type of treatment due to lack of proven clinical benefit (surgery, chemotherapy, standard radiotherapy, immunotherapy, targeted therapy, etc.).
Palliative Prognostic Index (PPI) =or< 2.
Metastatic disease in the central nervous system (CNS), if present, controlled (up to 3 metastases, each up to 1 cm).
Up to 5 extracranial distant metastases (nodal or extranodal) =or< 5 cm; signed Informed Consent Form (ICF).

: Cases in which tumor volume and/or the patient's clinical condition make adequate immobilization/simulation impossible.
Previous local radiotherapy.
Pregnant patients.
Autoimmune diseases.
Genetic instability syndromes.
Ongoing systemic therapy.
Renal insufficiency that prevents the use of iodinated contrast.

Hospital das Clínicas da Faculdade de Medicina da São Paulo - USP

Recruiting

Rua Dr. Ovídio Pires de Campos 785 - Estado de São Paulo 05403-000

SponsorUniversity of Sao Paulo General Hospital

Study typeInterventional

Conditions

Solid tumors

Requirements

From 18 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT07645261